Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
2018
• pT1a N0M0 human epidermal growth factor receptor 2 (HER2)-positive interval cancers have a poorer outcome than HER2-positive screen-detected (SD) cancers.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
46
References
1
Citations
NaN
KQI